Concepedia

Lilong Lin

LL

Statistics

Publications

12

Citations

683

H-Index

12

Active since

2015

Affiliations

Chinese Academy of Sciences(Current)

Guangzhou Institutes of Biomedicine and Health

Shenzhen Institutes of Advanced Technology

University of Chinese Academy of Sciences

Guangzhou Medical University

Lilong Lin is an author at Chinese Academy of Sciences specializing in life sciences, molecular biology, and medicine.

Publications per year

2015–2023

12

Publications

12

TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway

Yanfeng Liu, Shishi Tao, Lijuan Liao et al. · Nature Communications · 2020 · 274 citations · Full text

, , +17

Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy

Adeleye O. Adeshakin, Wan Liu, Funmilayo O. Adeshakin et al. · Cellular Immunology · 2021 · 121 citations

, , +16

Passive DNA demethylation preferentially up-regulates pluripotency-related genes and facilitates the generation of induced pluripotent stem cells

Songwei He, Hao Sun, Lilong Lin et al. · Journal of Biological Chemistry · 2017 · 61 citations · Full text

, , +14

Statin initiation and risk of incident kidney disease in patients with diabetes

Shiyu Zhou, Licong Su, Ruqi Xu et al. · Canadian Medical Association Journal · 2023 · 48 citations · Full text

, , +12

Metabolic switch and epithelial–mesenchymal transition cooperate to regulate pluripotency

Hao Sun, Xiao Yang, Lining Liang et al. · The EMBO Journal · 2020 · 38 citations · Full text

, , +17

1–5 of 12